I agree that this site is using cookies. You can find further informations here.
X
Durm, G.A.
22  results:
Search for persons X
?
1

Prognostic Performance of Sentinel Lymph Node Biopsy for th..:

Farlow, J.L. ; Jones, A.J. ; Xie, D.X....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e82 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Adjuvant Treatment Deintensification after Transoral Surger..:

Farlow, J.L. ; Jones, A.J. ; Xie, D.X....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e26 , 2024
Link: https://doi.org/10.1016/..
 
?
3

PP01.64 A Safety and Efficacy Analysis Comparing Elderly vs..:

Shahani, S. ; Durm, G. ; Althouse, S...
Journal of Thoracic Oncology.  18 (2023)  3 - p. e37-e38 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Evaluation of Pneumonitis in a Phase II Study of Consolidat..:

Weisman, M. ; Shields, M. ; Althouse, S...
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. S168-S169 , 2023
Link: https://doi.org/10.1016/..
 
?
5

OA03.06 CodeBreaK 100/101: First Report of Safety/Efficacy ..:

Li, B.T. ; Falchook, G.S. ; Durm, G.A....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S10-S11 , 2022
Link: https://doi.org/10.1016/..
 
?
6

MA06.05 Consolidation Nivolumab and Ipilimumab or Nivolumab..:

Durm, G.A. ; Mamdani, H. ; Althouse, S....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S64 , 2022
Link: https://doi.org/10.1016/..
 
?
7

EP14.05-004 Temozolomide and Atezolizumab as Second Line Tr..:

Owen, D.H. ; Durm, G.A. ; Wei, L....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S544-S545 , 2022
Link: https://doi.org/10.1016/..
 
?
8

A multi-center phase II trial evaluating the efficacy of pa..:

Swiecicki, P.L. ; Durm, G. ; Bellile, E....
International Journal of Radiation Oncology*Biology*Physics.  106 (2020)  5 - p. 1178-1179 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Factors Associated With Survival in Patients With Non–small..:

Zhang, H. ; Wang, W. ; Durm, G...
International Journal of Radiation Oncology*Biology*Physics.  99 (2017)  2 - p. E508-E509 , 2017
Link: https://doi.org/10.1016/..
 
?
10

CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advance..:

Naing, A ; Thistlethwaite, F ; De Vries, EGE...
https://discovery.ucl.ac.uk/id/eprint/10133504/1/e002447.full.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
11

KRAS(G12C) Inhibition with Sotorasib in Advanced Solid Tumo..:

Hong, D.S ; Fakih, M.G ; Strickler, J.H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571518/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
12

CX-072 (pacmilimab), a Probody®PD-L1 inhibitor, in advanced..:

Naing, Aung ; Thistlethwaite, Fiona ; De Vries, Elisabeth G.E....
Journal for ImmunoTherapy of Cancer.  9 (2021)  7 - p. e002447 , 2021
Link: https://doi.org/10.1136/..
 
?
13

P330 A prospective trial to evaluate the feasibility of a m..:

Coenen, S ; Weyts, E ; Geens, P...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S269-S269 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Relationship between colorectal cancer glutathione levels a..:

Barranco, Sam C. ; Perry, Roger R. ; Durm, Mary E....
Diseases of the Colon & Rectum.  43 (2000)  8 - p. 1133-1140 , 2000
Link: https://doi.org/10.1007/..
 
?
15

Making National Cancer Institute-Designated Comprehensive C..:

Kalra, Maitri ; Henry, Elizabeth ; McCann, Kelly...
10.2196/33859.  , 2022
Link: https://hdl.handle.net/1..
 
1-15